Mutation Interest in the Receptor-Binding Domain of Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 in the Northwest of Iran

Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity

(2023) Alina P. Sergeeva et al.   JOURNAL OF MOLECULAR BIOLOGY

Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis

(2023) Reetesh Kumar et al.   Viruses-Basel

The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters

(2022) Timothy Carroll et al.   PLoS Pathogens

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

(2022) Masaud Shah et al.   Frontiers in Immunology

From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants

(2022) Vasileios Papanikolaou et al.   GENE

From the Editor: COVID control case studies special issue

(2022) T. Renée Anthony   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants

(2022) Clauber Henrique Souza da Costa et al.   Scientific Reports

SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study)

(2022) Faezeh Hajizadeh et al.   MICROBIAL PATHOGENESIS

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

(2021) Pengfei Wang et al.   NATURE

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

(2021) Rita E. Chen et al.   NATURE MEDICINE

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications

(2021) Jasdeep Singh et al.   Viruses-Basel

Enhanced binding of the N501Y‐mutated SARS‐CoV‐2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations

(2021) Binquan Luan et al.   FEBS LETTERS

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

(2021) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

(2021) Ezgi Hacisuleyman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19

(2021) Rohitash Yadav et al.   Cells

The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection

(2021) Somaieh matin et al.   ARCHIVES OF MICROBIOLOGY

Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries

(2021) Alon Ben David et al.   MOLECULES

The Emerging Concern and Interest SARS-CoV-2 Variants

(2021) Edyta Janik et al.   Pathogens

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor

(2021) Cecylia S. Lupala et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

(2020) Qianqian Li et al.   CELL